Serum Leptin as a Biomarker in Diabetes

Abstract

Acromegaly is a rare disease caused by an overproduction of growth hormone and revealed by progressive clinical features. Due to the abundance of growth hormone receptors in the body, it is a systemic disease that leads to many complications and concomitant diseases. An obvious medical concern in the context of acromegaly is diabetes. It can be the result of excess growth hormone and its mediators, but it can also result from the treatment of acromegaly.